Clinical Trial of Targeted Alpha Therapy Using [At-211]PSMA-5 for Prostate Cancer
NCT06441994
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Prostate Cancer
Interventions
DRUG:
PSW-1025
Sponsor
Osaka University
Collaborators
[object Object]